US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sagimet Biosciences Inc.

9.14

-0.2300-2.45%

Post-market: 9.260.1246+1.36%19:54 EDT

Volume:1.71M

Turnover:15.58M

Market Cap:648.11M

PE:-7.32

High:9.38

Open:9.26

Low:8.88

Close:9.37

52wk High:11.45

52wk Low:4.50

Shares:70.91M

Float Shares:64.53M

Volume Ratio:0.78

T/O Rate:2.65%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2490

EPS(LYR):-1.5800

ROE:-24.37%

ROA:-16.41%

PB:2.53

PE(LYR):-5.78

Loading ...

Overview Company News Filings

Sagimet Biosciences holds a conference call

BRIEF-Sagimet Biosciences Offers 29.17 Million Shares Of Series A Common Stock - SEC Filing

Sagimet Biosciences Inc - Offering 29.17 Mln Shares of Series a Common Stock - SEC Filing

THOMSON REUTERS

NASD Most Active Issues

Top Midday Gainers

MT Newswires Live

Why Is Sagimet Biosciences Stock Trading Higher On Monday?

Sagimet Biosciences Shares Rise With Focus on Acne Treatment

Sagimet Highlights Pipeline Progress and Strategic Corporate Developments

Sagimet Biosciences Inc - Prices 29.2 Mln Series a Common Shares at $6.00 per Share

THOMSON REUTERS

Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock

Sagimet plans US Phase 3 denifanstat acne trial start in H2 2026

Sagimet Biosciences Inc - Plans Phase 3 Trial of Denifanstat in U.S. Acne Patients in H2 2026

THOMSON REUTERS

Sagimet Biosciences Provides Strategic and Corporate Updates

Sagimet Biosciences announces annual shareholder meeting notice

Sagimet Biosciences Appoints Andreas Grauer as Chief Medical Officer

Sagimet names Andreas Grauer chief medical officer as Eduardo Martins retires

Press Release: Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer

Sagimet grants 9,600 inducement stock options to new hire under Nasdaq rule exception

Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/SGMT/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SGMT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGMT\",,,,,undefined,":{"symbol":"SGMT","market":"US","secType":"STK","nameCN":"Sagimet Biosciences Inc.","latestPrice":9.14,"timestamp":1790971200000,"preClose":9.37,"halted":0,"volume":1712551,"hourTrading":{"tag":"盘后","latestPrice":9.2646,"preClose":9.14,"latestTime":"19:54 EDT","volume":98153,"amount":897196.3,"timestamp":1790985298988,"change":0.1246,"changeRate":0.013632,"amplitude":0.023479},"delay":0,"changeRate":-0.02454642475987179,"floatShares":64530800,"shares":70908700,"eps":-1.248952,"marketStatus":"Market Closed","change":-0.23,"latestTime":"10-02 16:00:00 EDT","open":9.26,"high":9.38,"low":8.88,"amount":15579650.151585,"amplitude":0.053362,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.248952,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":9.37,"preHourTrading":{"tag":"盘前","latestPrice":9.28,"preClose":9.37,"latestTime":"09:29 EDT","volume":3358,"amount":31044.149214,"timestamp":1790947799999,"change":-0.09,"changeRate":-0.009605,"amplitude":0.022113},"postHourTrading":{"tag":"盘后","latestPrice":9.2646,"preClose":9.14,"latestTime":"19:54 EDT","volume":98153,"amount":897196.3,"timestamp":1790985298988,"change":0.1246,"changeRate":0.013632,"amplitude":0.023479},"volumeRatio":0.7844773122741159,"impliedVol":1.1605,"impliedVolPercentile":0.5578},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGMT\",,,,,undefined,":{"symbol":"SGMT","floatShares":64530800,"roa":"-16.41%","roe":"-24.37%","lyrEps":-1.58,"volumeRatio":0.7844773122741159,"shares":70908700,"dividePrice":0,"high":9.38,"amplitude":0.053362,"preClose":9.37,"low":8.88,"week52Low":4.5,"pbRate":"2.53","week52High":11.449,"institutionHeld":0,"latestPrice":9.14,"eps":-1.248952,"divideRate":0,"volume":1712551,"delay":0,"ttmEps":-1.248952,"open":9.26,"prevYearClose":5.92,"prevWeekClose":9.24,"prevMonthClose":9.88,"prevQuarterClose":9.88,"fiveDayClose":9.24,"twentyDayClose":10.92,"sixtyDayClose":7.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SGMT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"SGMT","fiscalQuarterEnding":"2026/06","expectedEps":-0.28,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2026-05-12","symbol":"SGMT","fiscalQuarterEnding":"2026/03","expectedEps":-0.39,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.33},{"market":"US","date":"2026-03-11","symbol":"SGMT","fiscalQuarterEnding":"2025/12","expectedEps":-0.43,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773201600000,"reportTimeType":"pre","actualEps":-0.29},{"market":"US","date":"2025-11-13","symbol":"SGMT","fiscalQuarterEnding":"2025/09","expectedEps":-0.41,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-0.4},{"market":"US","date":"2025-08-13","symbol":"SGMT","fiscalQuarterEnding":"2025/06","expectedEps":-0.52,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SGMT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SGMT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3077,"buy":0.6154,"hold":0,"sell":0.0769,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6154,"analysts":13,"updateTime":1790308800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SGMT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SGMT","date":"2026-10-01","current":-7.318136,"percent":0.002558,"low":-15.666506,"twenty":-9.217833,"median":-4.445235,"eighty":-3.287097,"high":-1.342444,"avg":-5.685115,"sd":3.276424,"marketCap":700577590},"quantilePoints":[{"date":"2023-07-21","current":-12.287206,"twenty":-13.337015,"median":-12.553129,"eighty":-11.625533,"marketCap":348354576},{"date":"2023-07-28","current":-12.208993,"twenty":-12.714826,"median":-12.49838,"eighty":-12.113574,"marketCap":346137170},{"date":"2023-08-04","current":-12.733018,"twenty":-12.595364,"median":-12.529665,"eighty":-12.271563,"marketCap":360993794},{"date":"2023-08-11","current":-12.514023,"twenty":-12.565643,"median":-12.517933,"eighty":-12.42486,"marketCap":354785056},{"date":"2023-08-18","current":-9.925184,"twenty":-12.565643,"median":-12.514023,"eighty":-12.265307,"marketCap":281388897},{"date":"2023-08-25","current":-9.359416,"twenty":-12.554693,"median":-12.471006,"eighty":-10.020915,"marketCap":262381858},{"date":"2023-09-01","current":-9.85717,"twenty":-12.553129,"median":-12.459274,"eighty":-9.809842,"marketCap":276335907},{"date":"2023-09-08","current":-10.126447,"twenty":-12.543743,"median":-12.279385,"eighty":-9.775571,"marketCap":283884818},{"date":"2023-09-15","current":-9.791891,"twenty":-12.532793,"median":-11.532454,"eighty":-9.775571,"marketCap":274505868},{"date":"2023-09-22","current":-8.282308,"twenty":-12.524972,"median":-10.126447,"eighty":-9.674388,"marketCap":232186213},{"date":"2023-09-29","current":-7.392878,"twenty":-12.517151,"median":-9.936056,"eighty":-9.403479,"marketCap":207251930},{"date":"2023-10-06","current":-5.866975,"twenty":-12.514023,"median":-9.90613,"eighty":-8.80291,"marketCap":164474765},{"date":"2023-10-13","current":-4.757227,"twenty":-12.495252,"median":-9.80821,"eighty":-7.764969,"marketCap":133364100},{"date":"2023-10-20","current":-3.729078,"twenty":-12.478045,"median":-9.791891,"eighty":-6.978354,"marketCap":104540984},{"date":"2023-10-27","current":-3.647479,"twenty":-12.474916,"median":-9.751091,"eighty":-6.462648,"marketCap":102253435},{"date":"2023-11-03","current":-3.100765,"twenty":-12.467095,"median":-9.681732,"eighty":-5.866975,"marketCap":86926858},{"date":"2023-11-10","current":-2.284775,"twenty":-12.467095,"median":-9.514454,"eighty":-4.757227,"marketCap":64051369},{"date":"2023-11-17","current":-1.981702,"twenty":-12.459274,"median":-9.396135,"eighty":-4.030995,"marketCap":53347428},{"date":"2023-11-24","current":-3.487116,"twenty":-12.32162,"median":-9.116089,"eighty":-3.455541,"marketCap":93873157},{"date":"2023-12-01","current":-3.248971,"twenty":-12.280949,"median":-8.665823,"eighty":-3.326797,"marketCap":87462307},{"date":"2023-12-08","current":-3.436085,"twenty":-12.223071,"median":-7.870232,"eighty":-3.326797,"marketCap":92499403},{"date":"2023-12-15","current":-4.74588,"twenty":-11.827315,"median":-7.466317,"eighty":-3.305106,"marketCap":127759077},{"date":"2023-12-22","current":-4.79691,"twenty":-11.412789,"median":-6.927763,"eighty":-3.326797,"marketCap":129132830},{"date":"2023-12-29","current":-5.009539,"twenty":-10.856914,"median":-6.462648,"eighty":-3.351567,"marketCap":134856803},{"date":"2024-01-05","current":-4.286601,"twenty":-10.142767,"median":-6.27497,"eighty":-3.385054,"marketCap":115395295},{"date":"2024-01-12","current":-6.055674,"twenty":-10.126447,"median":-6.038333,"eighty":-3.402064,"marketCap":163018751},{"date":"2024-01-19","current":-5.494334,"twenty":-10.061168,"median":-5.928097,"eighty":-3.422477,"marketCap":147907462},{"date":"2024-01-26","current":-11.924235,"twenty":-11.412789,"median":-6.047003,"eighty":-3.434384,"marketCap":321000405},{"date":"2024-02-02","current":-11.8484,"twenty":-11.755197,"median":-6.332089,"eighty":-3.449693,"marketCap":318958920},{"date":"2024-02-09","current":-7.10904,"twenty":-11.755197,"median":-6.72671,"eighty":-3.480312,"marketCap":191375352},{"date":"2024-02-16","current":-10.260714,"twenty":-11.412789,"median":-7.18072,"eighty":-3.487116,"marketCap":276218424},{"date":"2024-02-23","current":-7.973973,"twenty":-11.272575,"median":-7.393401,"eighty":-3.512632,"marketCap":214659353},{"date":"2024-03-01","current":-7.263069,"twenty":-10.976358,"median":-7.495026,"eighty":-3.600344,"marketCap":195521817},{"date":"2024-03-08","current":-7.642218,"twenty":-10.478725,"median":-7.466317,"eighty":-3.696438,"marketCap":205728503},{"date":"2024-03-15","current":-5.118509,"twenty":-10.189946,"median":-7.39314,"eighty":-3.910228,"marketCap":137790253},{"date":"2024-03-22","current":-5.509506,"twenty":-10.132975,"median":-7.18072,"eighty":-4.056781,"marketCap":148315897},{"date":"2024-03-28","current":-6.56,"twenty":-10.093807,"median":-7.132737,"eighty":-4.084178,"marketCap":182866572},{"date":"2024-04-05","current":-6.239442,"twenty":-10.00568,"median":-6.795721,"eighty":-4.174333,"marketCap":173930684},{"date":"2024-04-12","current":-5.976126,"twenty":-9.938231,"median":-6.56,"eighty":-4.313817,"marketCap":166590490},{"date":"2024-04-19","current":-4.545061,"twenty":-9.925184,"median":-6.397368,"eighty":-4.392065,"marketCap":126698131},{"date":"2024-04-26","current":-4.487819,"twenty":-9.917562,"median":-6.217851,"eighty":-4.458405,"marketCap":125102437},{"date":"2024-05-03","current":-5.09459,"twenty":-9.886546,"median":-6.182199,"eighty":-4.468439,"marketCap":142016797},{"date":"2024-05-10","current":-5.231972,"twenty":-9.844114,"median":-6.079163,"eighty":-4.479356,"marketCap":145846463},{"date":"2024-05-17","current":-5.429865,"twenty":-9.811474,"median":-6.018678,"eighty":-4.487871,"marketCap":151590963},{"date":"2024-05-24","current":-5.372708,"twenty":-9.791891,"median":-5.987575,"eighty":-4.491214,"marketCap":149995268},{"date":"2024-05-31","current":-6.172899,"twenty":-9.791891,"median":-5.987575,"eighty":-4.501006,"marketCap":172334989},{"date":"2024-06-07","current":-5.315552,"twenty":-9.783731,"median":-5.976126,"eighty":-4.523122,"marketCap":148399574},{"date":"2024-06-14","current":-5.47559,"twenty":-9.751091,"median":-5.952111,"eighty":-4.533251,"marketCap":152867518},{"date":"2024-06-21","current":-4.446773,"twenty":-9.731508,"median":-5.91688,"eighty":-4.519544,"marketCap":124145020},{"date":"2024-06-28","current":-4.698262,"twenty":-9.718452,"median":-5.91688,"eighty":-4.523122,"marketCap":131166075},{"date":"2024-07-05","current":-3.257919,"twenty":-9.685812,"median":-5.888477,"eighty":-4.48795,"marketCap":90954577},{"date":"2024-07-12","current":-3.738033,"twenty":-9.677652,"median":-5.800519,"eighty":-4.448199,"marketCap":104358410},{"date":"2024-07-15","current":-3.806621,"twenty":-9.67602,"median":-5.796735,"eighty":-4.447058,"marketCap":106273243},{"date":"2024-08-02","current":-3.97809,"twenty":-9.674388,"median":-5.79295,"eighty":-4.391494,"marketCap":111060326},{"date":"2024-08-09","current":-3.109312,"twenty":-9.635837,"median":-5.632964,"eighty":-4.048186,"marketCap":86805772},{"date":"2024-08-16","current":-3.011259,"twenty":-9.556995,"median":-5.529634,"eighty":-3.765468,"marketCap":88082328},{"date":"2024-08-23","current":-3.174914,"twenty":-9.5049,"median":-5.509506,"eighty":-3.626007,"marketCap":92869411},{"date":"2024-08-30","current":-3.36039,"twenty":-9.480538,"median":-5.47559,"eighty":-3.517501,"marketCap":98294771},{"date":"2024-09-06","current":-2.913065,"twenty":-9.458966,"median":-5.429865,"eighty":-3.459899,"marketCap":85210078},{"date":"2024-09-13","current":-3.709522,"twenty":-9.418167,"median":-5.410329,"eighty":-3.440029,"marketCap":108507215},{"date":"2024-09-20","current":-3.578597,"twenty":-9.3382,"median":-5.372708,"eighty":-3.459899,"marketCap":104677549},{"date":"2024-09-27","current":-3.076721,"twenty":-9.217671,"median":-5.306102,"eighty":-3.426198,"marketCap":89997161},{"date":"2024-10-04","current":-4.495067,"twenty":-9.063099,"median":-5.281258,"eighty":-3.402458,"marketCap":131485214},{"date":"2024-10-11","current":-4.516888,"twenty":-9.008144,"median":-5.226248,"eighty":-3.408396,"marketCap":132123492},{"date":"2024-10-18","current":-5.891593,"twenty":-8.972181,"median":-5.273199,"eighty":-3.426198,"marketCap":172334989},{"date":"2024-10-25","current":-6.000697,"twenty":-8.935294,"median":-5.292689,"eighty":-3.429281,"marketCap":175526378},{"date":"2024-10-31","current":-5.826131,"twenty":-8.894301,"median":-5.311818,"eighty":-3.436085,"marketCap":170420156},{"date":"2024-11-08","current":-6.753511,"twenty":-8.791513,"median":-5.372708,"eighty":-3.436763,"marketCap":197546960},{"date":"2024-11-15","current":-5.651565,"twenty":-8.755967,"median":-5.41811,"eighty":-3.453095,"marketCap":165313934},{"date":"2024-11-22","current":-3.861691,"twenty":-8.665823,"median":-5.372708,"eighty":-3.487116,"marketCap":144879052},{"date":"2024-11-29","current":-4.882893,"twenty":-8.557843,"median":-5.315552,"eighty":-3.487116,"marketCap":183191513},{"date":"2024-12-06","current":-3.998995,"twenty":-8.332016,"median":-5.292689,"eighty":-3.504949,"marketCap":150030307},{"date":"2024-12-13","current":-3.896017,"twenty":-8.272608,"median":-5.273199,"eighty":-3.525595,"marketCap":146166866},{"date":"2024-12-20","current":-4.350838,"twenty":-8.042693,"median":-5.190447,"eighty":-3.550034,"marketCap":163230399},{"date":"2024-12-27","current":-4.35942,"twenty":-7.978712,"median":-5.107971,"eighty":-3.56885,"marketCap":163552352},{"date":"2025-01-03","current":-3.853109,"twenty":-7.96022,"median":-5.094591,"eighty":-3.578236,"marketCap":144557099},{"date":"2025-01-10","current":-4.608284,"twenty":-7.932249,"median":-5.088866,"eighty":-3.585335,"marketCap":172889002},{"date":"2025-01-17","current":-3.664315,"twenty":-7.891035,"median":-5.014451,"eighty":-3.578519,"marketCap":137474123},{"date":"2025-01-24","current":-3.561337,"twenty":-7.843641,"median":-5.001034,"eighty":-3.577995,"marketCap":133610681},{"date":"2025-01-31","current":-3.484103,"twenty":-7.800873,"median":-4.931489,"eighty":-3.565628,"marketCap":130713100},{"date":"2025-02-07","current":-4.041903,"twenty":-7.796247,"median":-4.899965,"eighty":-3.577995,"marketCap":151640074},{"date":"2025-02-14","current":-3.775875,"twenty":-7.711114,"median":-4.882893,"eighty":-3.5785,"marketCap":141659518},{"date":"2025-02-21","current":-3.454068,"twenty":-7.655997,"median":-4.848447,"eighty":-3.56477,"marketCap":129586263},{"date":"2025-02-28","current":-3.097934,"twenty":-7.585345,"median":-4.824006,"eighty":-3.534402,"marketCap":116225195},{"date":"2025-03-07","current":-3.13226,"twenty":-7.533213,"median":-4.786117,"eighty":-3.487116,"marketCap":117513009},{"date":"2025-03-14","current":-2.479989,"twenty":-7.4778,"median":-4.774032,"eighty":-3.471231,"marketCap":113005660},{"date":"2025-03-21","current":-2.861526,"twenty":-7.417463,"median":-4.751553,"eighty":-3.434384,"marketCap":130391147},{"date":"2025-03-28","current":-2.656626,"twenty":-7.395771,"median":-4.728869,"eighty":-3.400275,"marketCap":121054497},{"date":"2025-04-04","current":-1.603868,"twenty":-7.392983,"median":-4.702859,"eighty":-3.36039,"marketCap":73083433},{"date":"2025-04-11","current":-1.575606,"twenty":-7.289031,"median":-4.694849,"eighty":-3.31696,"marketCap":71795619},{"date":"2025-04-17","current":-1.42723,"twenty":-7.21366,"median":-4.648098,"eighty":-3.301626,"marketCap":65034596},{"date":"2025-04-25","current":-2.204435,"twenty":-7.173257,"median":-4.603993,"eighty":-3.254074,"marketCap":100449476},{"date":"2025-05-02","current":-2.77674,"twenty":-7.146955,"median":-4.575776,"eighty":-3.219588,"marketCap":126527705},{"date":"2025-05-09","current":-1.80385,"twenty":-7.118519,"median":-4.541885,"eighty":-3.18279,"marketCap":103025104},{"date":"2025-05-16","current":-1.865858,"twenty":-6.931314,"median":-4.533251,"eighty":-3.143037,"marketCap":106566591},{"date":"2025-05-23","current":-1.922228,"twenty":-6.7923,"median":-4.516125,"eighty":-3.120362,"marketCap":109786126},{"date":"2025-05-30","current":-1.972961,"twenty":-6.768572,"median":-4.505306,"eighty":-3.099066,"marketCap":112683707},{"date":"2025-06-06","current":-2.694501,"twenty":-6.722029,"median":-4.495067,"eighty":-3.076721,"marketCap":153893749},{"date":"2025-06-13","current":-4.853485,"twenty":-6.632098,"median":-4.487884,"eighty":-3.076721,"marketCap":277201920},{"date":"2025-06-20","current":-3.968471,"twenty":-6.566428,"median":-4.480766,"eighty":-3.076721,"marketCap":226655228},{"date":"2025-06-27","current":-4.904218,"twenty":-6.557243,"median":-4.495067,"eighty":-3.078851,"marketCap":280099501},{"date":"2025-07-03","current":-4.650551,"twenty":-6.546215,"median":-4.495067,"eighty":-3.087373,"marketCap":265611596},{"date":"2025-07-11","current":-5.586299,"twenty":-6.535304,"median":-4.505306,"eighty":-3.097934,"marketCap":319055868},{"date":"2025-07-18","current":-5.383366,"twenty":-6.492923,"median":-4.516888,"eighty":-3.100765,"marketCap":307465544},{"date":"2025-07-25","current":-5.749773,"twenty":-6.480752,"median":-4.529894,"eighty":-3.109312,"marketCap":328392519},{"date":"2025-08-01","current":-4.898581,"twenty":-6.480752,"median":-4.538709,"eighty":-3.120362,"marketCap":279777548},{"date":"2025-08-08","current":-5.101514,"twenty":-6.462648,"median":-4.566286,"eighty":-3.120362,"marketCap":291367872},{"date":"2025-08-15","current":-5.891315,"twenty":-6.437111,"median":-4.599703,"eighty":-3.13226,"marketCap":349838046},{"date":"2025-08-22","current":-4.025357,"twenty":-6.382559,"median":-4.566286,"eighty":-3.13419,"marketCap":239033752},{"date":"2025-08-29","current":-4.140367,"twenty":-6.360738,"median":-4.538709,"eighty":-3.140842,"marketCap":245863288},{"date":"2025-09-05","current":-3.97059,"twenty":-6.343282,"median":-4.533251,"eighty":-3.141915,"marketCap":235781592},{"date":"2025-09-12","current":-3.85558,"twenty":-6.333455,"median":-4.518739,"eighty":-3.143321,"marketCap":228952056},{"date":"2025-09-19","current":-3.696756,"twenty":-6.268752,"median":-4.505306,"eighty":-3.155125,"marketCap":219520793},{"date":"2025-09-26","current":-3.910347,"twenty":-6.242137,"median":-4.495589,"eighty":-3.161438,"marketCap":232204216},{"date":"2025-10-03","current":-3.9213,"twenty":-6.222169,"median":-4.487819,"eighty":-3.17239,"marketCap":232854648},{"date":"2025-10-10","current":-4.720895,"twenty":-6.216806,"median":-4.469318,"eighty":-3.185415,"marketCap":280336183},{"date":"2025-10-17","current":-4.134891,"twenty":-6.207386,"median":-4.448199,"eighty":-3.194996,"marketCap":245538072},{"date":"2025-10-24","current":-4.014404,"twenty":-6.179338,"median":-4.440945,"eighty":-3.205463,"marketCap":238383320},{"date":"2025-10-31","current":-4.458014,"twenty":-6.166061,"median":-4.448199,"eighty":-3.212557,"marketCap":264725815},{"date":"2025-11-07","current":-4.211564,"twenty":-6.160312,"median":-4.446004,"eighty":-3.221522,"marketCap":250091096},{"date":"2025-11-14","current":-4.238947,"twenty":-6.115309,"median":-4.446773,"eighty":-3.228264,"marketCap":251717176},{"date":"2025-11-21","current":-4.099669,"twenty":-6.104311,"median":-4.436499,"eighty":-3.233938,"marketCap":236432024},{"date":"2025-11-28","current":-4.071473,"twenty":-6.101058,"median":-4.420471,"eighty":-3.243405,"marketCap":234805944},{"date":"2025-12-05","current":-3.580867,"twenty":-6.095284,"median":-4.404184,"eighty":-3.254074,"marketCap":206512153},{"date":"2025-12-12","current":-3.569588,"twenty":-6.08465,"median":-4.372292,"eighty":-3.257742,"marketCap":205861721},{"date":"2025-12-19","current":-3.360939,"twenty":-6.079163,"median":-4.354642,"eighty":-3.257919,"marketCap":193828730},{"date":"2025-12-26","current":-3.417331,"twenty":-6.078325,"median":-4.333675,"eighty":-3.272875,"marketCap":197080889},{"date":"2026-01-02","current":-3.338383,"twenty":-6.07279,"median":-4.295418,"eighty":-3.296029,"marketCap":192527866},{"date":"2026-01-09","current":-3.141012,"twenty":-6.052206,"median":-4.275812,"eighty":-3.257565,"marketCap":181145306},{"date":"2026-01-16","current":-3.530114,"twenty":-6.030806,"median":-4.260854,"eighty":-3.257919,"marketCap":203585209},{"date":"2026-01-23","current":-3.580867,"twenty":-6.000697,"median":-4.24786,"eighty":-3.257919,"marketCap":206512153},{"date":"2026-01-30","current":-3.02259,"twenty":-5.999023,"median":-4.239278,"eighty":-3.257919,"marketCap":174315770},{"date":"2026-02-06","current":-3.067703,"twenty":-5.987575,"median":-4.238947,"eighty":-3.257919,"marketCap":176917498},{"date":"2026-02-13","current":-2.904167,"twenty":-5.987575,"median":-4.207457,"eighty":-3.229466,"marketCap":167486234},{"date":"2026-02-20","current":-3.033868,"twenty":-5.978416,"median":-4.198491,"eighty":-3.205597,"marketCap":174966202},{"date":"2026-02-27","current":-3.310187,"twenty":-5.976126,"median":-4.171404,"eighty":-3.19727,"marketCap":190901786},{"date":"2026-03-06","current":-3.073342,"twenty":-5.960869,"median":-4.151321,"eighty":-3.194996,"marketCap":177242714},{"date":"2026-03-13","current":-3.409312,"twenty":-5.933889,"median":-4.134891,"eighty":-3.179372,"marketCap":174004471},{"date":"2026-03-20","current":-3.083704,"twenty":-5.922747,"median":-4.112984,"eighty":-3.173773,"marketCap":157386066},{"date":"2026-03-27","current":-3.262469,"twenty":-5.915013,"median":-4.099669,"eighty":-3.155125,"marketCap":166509896},{"date":"2026-04-02","current":-3.345467,"twenty":-5.912776,"median":-4.084811,"eighty":-3.143037,"marketCap":170745960},{"date":"2026-04-10","current":-3.600846,"twenty":-5.910928,"median":-4.072723,"eighty":-3.152245,"marketCap":183780003},{"date":"2026-04-17","current":-3.951993,"twenty":-5.905493,"median":-4.058653,"eighty":-3.16058,"marketCap":201701812},{"date":"2026-04-24","current":-3.74769,"twenty":-5.895957,"median":-4.054569,"eighty":-3.166443,"marketCap":191274578},{"date":"2026-05-01","current":-9.715643,"twenty":-5.895957,"median":-4.071473,"eighty":-3.172632,"marketCap":495867010},{"date":"2026-05-08","current":-9.243775,"twenty":-5.916612,"median":-4.077048,"eighty":-3.178257,"marketCap":471783805},{"date":"2026-05-15","current":-10.459432,"twenty":-5.976126,"median":-4.099487,"eighty":-3.185018,"marketCap":455110817},{"date":"2026-05-22","current":-9.934332,"twenty":-5.999693,"median":-4.106949,"eighty":-3.193257,"marketCap":432262649},{"date":"2026-05-29","current":-10.317513,"twenty":-6.068511,"median":-4.112984,"eighty":-3.197003,"marketCap":448935636},{"date":"2026-06-05","current":-10.019483,"twenty":-6.096486,"median":-4.130758,"eighty":-3.2015,"marketCap":435967757},{"date":"2026-06-12","current":-9.125393,"twenty":-6.162332,"median":-4.137629,"eighty":-3.210101,"marketCap":397064119},{"date":"2026-06-18","current":-9.267312,"twenty":-6.214255,"median":-4.165012,"eighty":-3.21502,"marketCap":403239299},{"date":"2026-06-26","current":-9.735645,"twenty":-6.316255,"median":-4.173227,"eighty":-3.220659,"marketCap":423617396},{"date":"2026-07-02","current":-10.587159,"twenty":-6.382559,"median":-4.200611,"eighty":-3.223456,"marketCap":460668480},{"date":"2026-07-10","current":-10.431048,"twenty":-6.480752,"median":-4.221131,"eighty":-3.225599,"marketCap":453875781},{"date":"2026-07-17","current":-10.856806,"twenty":-6.56,"median":-4.239278,"eighty":-3.229466,"marketCap":472401323},{"date":"2026-07-24","current":-9.948524,"twenty":-6.778613,"median":-4.241851,"eighty":-3.235056,"marketCap":432880167},{"date":"2026-07-31","current":-10.374281,"twenty":-7.139846,"median":-4.251619,"eighty":-3.241664,"marketCap":451405709},{"date":"2026-08-07","current":-12.403723,"twenty":-7.392983,"median":-4.260854,"eighty":-3.247188,"marketCap":539710793},{"date":"2026-08-14","current":-12.252433,"twenty":-7.533213,"median":-4.28742,"eighty":-3.248808,"marketCap":576832299},{"date":"2026-08-21","current":-13.440708,"twenty":-7.797172,"median":-4.325957,"eighty":-3.255775,"marketCap":632775087},{"date":"2026-08-28","current":-14.193282,"twenty":-7.946467,"median":-4.35274,"eighty":-3.25783,"marketCap":668205519},{"date":"2026-09-04","current":-14.417734,"twenty":-8.332016,"median":-4.368001,"eighty":-3.257919,"marketCap":678772490},{"date":"2026-09-11","current":-14.602577,"twenty":-8.770185,"median":-4.402327,"eighty":-3.260649,"marketCap":687474702},{"date":"2026-09-18","current":-14.74781,"twenty":-8.958862,"median":-4.412012,"eighty":-3.273961,"marketCap":694312154},{"date":"2026-09-25","current":-12.027981,"twenty":-9.1481,"median":-4.436344,"eighty":-3.281622,"marketCap":566265328},{"date":"2026-10-01","current":-14.880894,"twenty":-9.217833,"median":-4.445235,"eighty":-3.287097,"marketCap":700577590}],"updateTime":1790982986259},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SGMT\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2631582664","title":"Sagimet Biosciences holds a conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2631582664","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631582664?lang=en_us&edition=fundamental","pubTime":"2026-04-29 01:15","pubTimestamp":1777396516,"startTime":"0","endTime":"0","summary":"Conference call with Julie Harper who will provide details on the acne program to be held on April 30 at 2 pm hosted by Sagimet Biosciences (SGMT)....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-holds-a-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-holds-a-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630370717","title":"BRIEF-Sagimet Biosciences Offers 29.17 Million Shares Of Series A Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2630370717","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630370717?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:33","pubTimestamp":1777372392,"startTime":"0","endTime":"0","summary":"BRIEF-Sagimet Biosciences Offers 29.17 Million Shares Of Series A Common Stock - SEC FilingApril 28  - SEC Filing:SAGIMET BIOSCIENCES INC - OFFERING 29.17 MILLION SHARES OF SERIES A COMMON STOCK - SEC FILINGSource text: [ID:n0001104659-26-049662]Further company coverage: SGMT.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41B0EW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630377677","title":"Sagimet Biosciences Inc - Offering 29.17 Mln Shares of Series a Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2630377677","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630377677?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:13","pubTimestamp":1777371212,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41B0EW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630336343","title":"NASD Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2630336343","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630336343?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:43","pubTimestamp":1777326180,"startTime":"0","endTime":"0","summary":"GrShr 2x Sh NVDA Daily       NVD    86,032,989      4.81    -0.42     -8.03. Direxion TSLA Bull 2X       TSLL    85,596,829     12.32     0.15      1.23. Leverage 2X Lg TSLA Dly     TSLG    70,827,573      6.07     0.07      1.17. Leverage 2X Lg BMNR Dly     BMNG    58,643,668      1.39    -0.08     -5.44. ProShares UltraPro QQQ      TQQQ    54,954,708     62.64     0.08      0.13. Advanced Micro Devices       AMD    50,381,910    334.63   -13.18     -3.79. Direxion PLTR Bear 1X       PLTD    43,573,521      7.55     0.00      0.00. American Airlines Group      AAL    42,375,758     11.68    -0.42     -3.47","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDB","LU0133085943.USD","SGXZ51526630.SGD","HK0000320223.HKD","LU2471134879.HKD","BMNG","IE00BMPRXR70.SGD","GRAB","SG9999015952.SGD","LU0320765059.SGD","LU2249611893.SGD","IE00BJTD4N35.SGD","LU1645745479.HKD","LU1244550494.USD","BK4614","LU0157215616.USD","LU0441851309.USD","LU0528227936.USD","LU2362540622.SGD","IE0002270589.USD","LU0080751232.USD","LU0557290698.USD","LU1815333072.USD","MUD","BK4534","BK4230","LU0354030511.USD","LU2148611432.USD","LU2294711713.HKD","IE0009G5SDU7.USD","LU0353189763.USD","LU2417539215.USD","LU0174119429.USD","LU1923623000.USD","LU0979878070.USD","IE00B19Z8W00.USD","LU2552382215.SGD","SG9999004303.SGD","LU0289960550.SGD","LU2357305700.SGD","LU2168564222.USD","LU1989764664.SGD","LU2054465674.USD","IE0004086264.USD","IE00B3S45H60.SGD","LU2462591277.SGD","NVII","BK4511","LU2271345857.HKD","LU0476273544.USD","IE00B19Z3581.USD","LU0708995401.HKD","LU2237957902.USD","LU0077335932.USD","BK4554","LU2125910500.SGD","LU1935042991.SGD","IE00BHPRN162.USD","HK0000819398.USD","LU1064131342.USD","LU0965509101.SGD","LU1974910355.USD","LU1988902786.USD","LU2028103732.USD","TSLW","BK4500","LU0061474960.USD","LU2250418816.HKD","LU1116320737.USD","LU2125909593.SGD","BK4605","SG9999014575.USD","LU0225283273.USD","IE000KEQY171.SGD","LU1852331112.SGD","IE00B1XK9C88.USD","LU2092937148.SGD","LU0107464264.USD","SG9999014906.USD","LU0672654240.SGD","LU2458330243.SGD","SG9999013486.USD","LU0069063385.USD","LU2168564495.EUR","LU0128525929.USD","SG9999001135.SGD","LU1868837136.USD","LU2098885051.SGD","LU0787776722.HKD","LU0109391861.USD","LU0964807845.USD","TSLT","LU0466842654.USD","LU2750360997.AUD","IE00BN29S564.USD","IE00B775SV38.USD","NVDD","LU0210637038.USD","LU2860962120.EUR","LU1934455277.USD","LU2290526834.HKD","LU0316494557.USD","LU2430703095.HKD","LU1868837300.USD","AMDW","LU1153585028.USD","GB00BDT5M118.USD","SOFI","HK0000914660.USD","LU1323610961.USD","HK0000304805.HKD","LU1815336760.USD","LU2357125470.USD","SG9999015341.SGD","SG9999013478.USD","LU0079474960.USD","LU0267386448.USD","LU1720051108.HKD","NVDX","TSLO","LU0175139822.USD","LU2047632596.USD","LU2077746001.SGD","AMDD","LU2750360641.GBP","LU0097036916.USD","TESL","SG9999001424.SGD","LU0345770308.USD","LU1642822529.SGD","LU2954938101.SGD","LU1435385759.SGD","LU2236285917.USD","LU2355687059.USD","BK4503","IE00BFSS7M15.SGD","SG9999002406.SGD","IE00BDCRKT87.USD","IE00B3M56506.USD","BK4551","LU1232071149.USD","AMDG","IE0034235303.USD","IE00BKPKM429.USD","IE0005OL40V9.USD","LU1400636657.SGD","BK4515","SG9999002414.USD","BK4587","LU1551013425.SGD","LU0048584097.USD","LU1316542783.SGD","SG9999014898.SGD","AMDY","LU0256863902.USD","LU0861579265.USD","LU2361044865.SGD","NVDL","AAPL","LU2023250330.USD","LU2381873111.SGD","LU0823434740.USD","LU2413666699.HKD","NDX","LU0187121727.USD","BK4566","IE00BD6J9T35.USD","LU0203345920.USD","LU0820561909.HKD","LU1267930573.SGD","LU1670756490.USD","LU1861215975.USD","SGXZ58947870.SGD","LU0265550359.USD","LU1923622614.USD","LU1935042215.USD","LU2452424414.USD","AMYY","LU1571399168.USD","LU2097344357.USD","LU2461242641.AUD","IE00BJJMRY28.SGD","SG9999002679.SGD","2NVD.UK","LU0820562030.AUD","NVDS.UK","LU1244550221.USD","LU2462591350.SGD","LU2286300806.USD","SG9999015986.USD","LU1623119135.USD","LU2362541513.USD","TSLA","IE00BVYPNP33.GBP","LU1366333091.USD","LU1861127337.USD","LU2106854487.HKD","LU0310799852.SGD","IE00B19Z9505.USD","LU0683600562.USD","LU0158827781.USD","LU1267930490.SGD","IE00BZ1G4Q59.USD","LU0289739343.SGD","LU0321505868.SGD","LU0786609619.USD","TSLR","LU1069344957.HKD","SG9999002224.SGD","LU1429558221.USD","LU1989772840.SGD","LU0957791311.USD","LU0788109477.HKD","IE00BZ199S13.USD","LU1127390331.HKD","LU2272731782.SGD","LU2463028550.USD","LU0096362180.USD","BK4612","LU0211327993.USD","LU1119994496.HKD","IE000ITXATA3.USD","LU0256863811.USD","LU3102509885.SGD","LU0143551892.USD","LU1803068979.SGD","LU0342679015.USD","LU1992135399.USD","LU2087625088.SGD","LU2322448957.HKD","LU0210536198.USD","LU0198837287.USD","LU0689472784.USD","BK4598","LU0417517546.SGD","SG9999002604.SGD","TEST","LU1989764748.USD","LU2063271972.USD","LU2543165471.USD","NVDA","PLTR","ANV","LU2505996509.AUD","LU0444971666.USD","HK0000532082.HKD","BK4549","LU0210528500.USD","LU1046421795.USD","BK4579","LINT","LU2108987350.USD","LU2471134796.USD","LU2089283258.USD","LU2237438978.USD","LU1914381329.SGD","LU2487616109.SGD","QCML","LU1202635105.USD","IE00BDRTCR15.USD","TSLZ","LU2083900584.USD","LU2168563687.JPY","LU0823421333.USD","LU2089284900.SGD","LU2125909916.SGD","LU1267930730.SGD","LU1778281490.HKD","AMD","IE0001KFT4U8.USD","IE0004445015.USD","LU1066051225.USD","LU2473716301.USD","NVDU","LU2756315318.SGD","CRSH","LU2360032135.SGD","LU2360106780.USD","SG9999014914.USD","IE000W1ABFV2.USD","LU1699723380.USD","LU0348723411.USD","LU1267930813.SGD","BK4022","LU2272731865.HKD","BK4529","BK4533","LU2896262040.SGD","LU1116320901.HKD","LU1814569148.SGD","LU1868836914.USD","LU2125154778.USD","LU2505996681.GBP","TSL","LU2420271590.USD","QCMD","LU2065169927.USD","LU2999663052.SGD","LU2602419157.SGD","IE00B4YYXB79.USD","LU1366192091.USD","DIPS","LU2433249047.HKD","LU0511384066.AUD","LU0109392836.USD","DAMD","IE000M9KFDE8.USD","LU1935042488.USD","LU2087621335.USD","LU2048586759.USD","BK4099","BK4512","LU0210533765.USD","LU2065171311.SGD","SGMT","TSLL","LU0061474705.USD","TSLG","LU0390134368.USD","LU2065171402.SGD","LU2168564065.EUR","LU0203201768.USD","LU1868836757.USD","IE00B19Z3B42.SGD","LU0081259029.USD","LU0345768153.USD","LU1880398554.USD","3NVD.UK","LU2242650005.HKD","LU2403377893.USD","SGXZ99366536.SGD","LU1242518857.USD","LU0154236417.USD","LU2092627202.USD","IE00BVYPNQ40.USD","IE0034235188.USD","LU2456880835.USD","LU1861558580.USD","BK4535","LU1839511570.USD","SG9999002620.SGD","SG9999013460.SGD","QCOM","LU1066053197.SGD","BK4141","SG9999015945.SGD","AMDL","LU1037948897.HKD","IE00B19Z8X17.USD","LU0345769631.USD","SG9999015978.USD","LU0823414551.USD","SG9999017495.SGD","SGXZ81514606.USD","LU2244417387.USD","IE00BQXX3C00.GBP","HK0000304797.USD","LU0251132253.USD","LU2360107168.USD","MUU","TSII","AALG","LU0094547139.USD","LU1983260115.SGD","LU2168564149.EUR","LU0310800379.SGD","AMZN","LU0889565833.HKD","LU2065170008.USD","AAL","IE0004091025.USD","LU0006306889.USD","BK4574","NVDO","BK4604","LU0082616367.USD","IE00BMPRXQ63.HKD","LU2242649171.HKD","BK4608","IE00B7SZLL34.SGD","LU2111349929.HKD","IE00BSNM7G36.USD","LU2023251221.USD","IE0003U64NQ7.SGD","SG9999000418.SGD","TSYY","LU0345770993.USD","LU1674673428.USD","IE00BKVL7J92.USD","LU0444973449.USD","LU1674673691.USD","SNVD.UK","BK4561","LU0070217475.USD","LU2462157665.USD","TLA","LU1861220033.SGD","LU2471134523.USD","IE00BYXW3230.USD","LU1917777945.USD","IE00BGHQDM52.EUR","LU1145028129.USD","LU2413666426.HKD","LU0215105999.USD","LU2491049909.HKD","LU0532188223.SGD","LU1951200564.SGD","IE00B1BXHZ80.USD","LU2592432038.USD","LU2430703178.SGD","LU1633808545.USD","LU1823568750.SGD","LU1261432733.SGD","LU0011850046.USD","SGXZ23171101.USD","LU2211815571.USD","LU1691799644.USD","BK4581","LU1935043023.USD","LU1084165304.USD","LU2458330169.SGD","LU0124676726.USD","SG9999014559.SGD","LU0323591593.USD","LU0494093205.USD","LU1821325948.USD","SG9999014567.USD","BK4527","TSLQ","LU0792757196.USD","LU0889566641.SGD","LU2931357623.SGD","LU0708994859.HKD","BK4588","LU1934455194.USD","NVIW.SI","IE00BMPRXN33.USD","MULL","HK0000306701.USD","IE0009356076.USD","LU0274383776.USD","IE00B7KXQ091.USD","TSLP","07766","LU1720051017.SGD","LU0029864427.USD","SG9999018857.SGD","LU2272731600.USD","LU0203347892.USD","LU1721428933.USD","LU0882574139.USD","LU1992135472.HKD","LU0724617625.USD","LU2491050071.SGD","NVD2.UK","LU1923622291.USD",".IXIC","LU0170899867.USD","IE00BJJMRX11.SGD","BK4008","LU0354030438.USD","LU0719512351.SGD","LU1496350502.SGD","IE000YTNTUN2.SGD","IE00B775H168.HKD","LU0096364046.USD","LU2362541273.HKD","LU0347712357.USD","BK4575","LU2756315664.SGD","NVD","LU0127658192.USD","BK4555","LU0106261372.USD","LU2045819591.USD","LU1244550577.SGD","SG9999002232.USD","LU0345769128.USD","LU0943347566.SGD","LU1861559042.SGD","LU0203202063.USD","INTC","LU0823421416.USD","LU0238689110.USD","LU1280957306.USD","LU1066051811.HKD","LU0965508806.USD","LU0820561818.USD","AMDU","IE00B3SWFQ91.USD","LU1242518931.SGD","LU2264538146.SGD","LU0266013472.USD","LU0985320562.USD","LU2506951792.HKD","LU1718418525.SGD","LU2552382132.HKD","TSLS","LU0308772762.SGD","LU0823414478.USD","LU0234572021.USD","BK4122","LU2326559502.SGD","LU2125909247.SGD","HK0000914686.HKD","LU2430703251.USD","IE00BWXC8680.SGD","LU0689626769.HKD","LU1868836591.USD","LU0942090050.USD","NVDS","BK4548","BK4543","BK4602","LU2552382058.USD","LU2023250504.SGD","LU1951198990.SGD","LU0061475181.USD","BYND","LU2746668974.SGD","LU2213496289.HKD","BK4532","CRML","LU0642271901.SGD","LU0957808578.USD","IE00BFSS8Q28.SGD","NVDQ","TSDD","LU0472753341.HKD","LU0868494708.USD","LU1791710400.SGD","LU0965509010.AUD","LU0057025933.USD","LU1066051498.USD","BK4516","LU1880398471.USD","LU0053666078.USD","BK4573","IE00B5949003.HKD","LU0823434583.USD","LU1839390173.USD","LU1400636574.HKD","TQQQ","LU2361045086.USD","IE00BKDWB100.SGD","LU2089985449.USD","SG9999015358.SGD","LU2746668461.USD","SG9999006266.SGD","SG9999014542.SGD","IE00BK4W5M84.HKD","LU1934455863.HKD","LU2125154935.USD","SGXZ31699556.SGD","SG9999018865.SGD","IE00B4JS1V06.HKD","IE00BK4W5L77.USD","LU1935043536.SGD","LU1989772923.USD","NVD3.UK","LU0353189680.USD","LU2097344431.USD","LU0868494617.USD","BK4553","BK4567","LU1496350171.SGD","IE0034235295.USD","IE00BJLML261.HKD","LU2322448791.USD","NVDW","HK0000306685.HKD","04335","LU0056508442.USD","LU0211328371.USD","LU0234570918.USD","LU0276348264.USD","LU1400636491.USD","AMUU","LU2237957811.SGD","NVDY","LU1548497426.USD","NVDG","LU0265550946.USD","LU1551013342.USD","LU2125909759.SGD","BK4547","BK4550","IE00BQXX3F31.USD","LU2191332357.HKD","LU1804176565.USD","LU2100268510.USD","LU0345768740.USD","BK4592","SG9999014880.SGD","TSLI","QCMU","LU0072462426.USD","BMNR","LU0965509283.SGD","LU1035775433.USD","LU1712237335.SGD","LU0289961442.SGD","LU1037948541.HKD","LU0823411888.USD","LU2247934214.USD","LU1629891620.HKD","LU0640476718.USD","TSLY","PLTD","INTW","IE00BQXX3D17.EUR","HK0000320264.USD","MU","LU2361044949.HKD","LU2471134952.CNY","LU2491050154.USD","LU0321505439.SGD","LU1791710582.SGD","IE0004445239.USD","LU0158827948.USD","LU1303367103.USD","BK4585","IE00BJTD4V19.USD","LU2265009873.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630113053","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2630113053","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630113053?lang=en_us&edition=fundamental","pubTime":"2026-04-28 02:01","pubTimestamp":1777312877,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences (SGMT) said Monday it has priced an underwritten offering of about 29.2 million shares at $6.00 each to raise about $175 million to help fund its clinical trial.Shares soared 43% a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ORKA","MANE","SGMT","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630031131","title":"Why Is Sagimet Biosciences Stock Trading Higher On Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2630031131","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630031131?lang=en_us&edition=fundamental","pubTime":"2026-04-28 01:48","pubTimestamp":1777312080,"startTime":"0","endTime":"0","summary":"Sagimet shares surge as Phase 3 acne trial plans and $175M offering fund pipeline through 2028, with technicals showing strong momentum.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/27/Healthcare-Funding-Pressure.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/27/Healthcare-Funding-Pressure.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/04/52073823/why-is-sagimet-biosciences-stock-trading-higher-on-monday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/04/52073823/why-is-sagimet-biosciences-stock-trading-higher-on-monday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4150","RSI","SGMT","SMA","BK4139","BK4217"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630456396","title":"Sagimet Biosciences Shares Rise With Focus on Acne Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2630456396","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630456396?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:02","pubTimestamp":1777291320,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences shares rose after the company said it would focus on advancing development of its acne treatment in the U.S.The stock climbed 29% to $7.55 in premarket trading Monday. Through Friday's close, the stock had ticked down 1% this year.The clinical-stage biopharmaceutical company said it plans to start a U.S. Phase 3 trial of denifanstat, a treatment for moderate to severe acne, in the second half of this year.The decision marks a broader strategic shift to prioritize Sagimet's dermatology business while pursuing nondilutive funding options for its program in the liver disease MASH, or metabolic dysfunction-associated steatohepatitis, Chief Financial Officer Thierry Chauche said.Sagimet had also been developing a combination of denifanstat and resmetirom to treat MASH. The company reported the completion of a Phase 1 trial in December 2025, and expects the combination treatment to be ready for a Phase 2 trial in the second half of this year.In January, Sagimet's license ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","01672","BK1515","BK1161","BK1574","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630951923","title":"Sagimet Highlights Pipeline Progress and Strategic Corporate Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2630951923","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630951923?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:37","pubTimestamp":1777289877,"startTime":"0","endTime":"0","summary":"The latest update is out from Sagimet Biosciences, Inc. Class A ( ($SGMT) ). On April 27, 2026, Sagimet updated its investor slide presentation and...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sagimet-highlights-pipeline-progress-and-strategic-corporate-developments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sagimet-highlights-pipeline-progress-and-strategic-corporate-developments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4097","LU2065732104.USD","PRGS","BK4139","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630039318","title":"Sagimet Biosciences Inc - Prices 29.2 Mln Series a Common Shares at $6.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2630039318","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630039318?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:15","pubTimestamp":1777288504,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA3LNMZ5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630482393","title":"Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2630482393","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630482393?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:15","pubTimestamp":1777288500,"startTime":"0","endTime":"0","summary":"SAN MATEO, Calif., April  27, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabol","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3281497/0/en/Sagimet-Biosciences-Announces-Pricing-of-175-0-Million-Underwritten-Offering-of-Series-A-Common-Stock.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","USA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630393830","title":"Sagimet plans US Phase 3 denifanstat acne trial start in H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2630393830","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630393830?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:06","pubTimestamp":1777287982,"startTime":"0","endTime":"0","summary":"Sagimet shifted capital focus to dermatology, planning a US Phase 3 trial of once-daily oral denifanstat in moderate to severe acne in 2H 2026, subject to IND clearance.Positive topline results were already reported from an open-label Phase 3 long-term safety study of denifanstat in China, showing it was generally well tolerated and supported improvements across measured efficacy outcomes.Development of FASN inhibitor TVB-3567 continued in a first-in-human Phase 1 trial, with Phase 2 in acne targeted for 2H 2026.MASH program for denifanstat plus resmetirom was positioned as Phase 2-ready in 2H 2026, with further clinical work deferred until non-dilutive funding is secured.Sagimet scheduled a KOL webcast for April 30, 2026 to outline its acne development strategy for denifanstat.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL6cVw3k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","SG9999014039.USD","BK4112","IE00BKPKM429.USD","SG9999014021.USD","LU2210150020.SGD","SGMT","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","BK4139","LU0314104364.USD","BK4585","IE00BN0W2T93.GBP","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4588","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630989453","title":"Sagimet Biosciences Inc - Plans Phase 3 Trial of Denifanstat in U.S. Acne Patients in H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2630989453","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630989453?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:00","pubTimestamp":1777287603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA6XFJTY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630393354","title":"Sagimet Biosciences Provides Strategic and Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2630393354","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630393354?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:00","pubTimestamp":1777287600,"startTime":"0","endTime":"0","summary":"Phase 3 clinical trial of denifanstat in moderate to severe acne patients for the U.S.planned to initiate in second half of 2026 First-in-human Phase 1 clinical trial of FASN inhibitor TVB-3567 ongoin","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3281481/0/en/Sagimet-Biosciences-Provides-Strategic-and-Corporate-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00511","BK1145","BK4139","SGMT","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629841050","title":"Sagimet Biosciences announces annual shareholder meeting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2629841050","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629841050?lang=en_us&edition=fundamental","pubTime":"2026-04-22 04:13","pubTimestamp":1776802401,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences schedules virtual annual stockholder meeting for June 12, 2026.Shareholders will vote on election of four Class III directors for terms expiring in 2029.Ballot also includes ratification of KPMG as independent registered public accounting firm for fiscal 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sagimet Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL5gFpbC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629756080","title":"Sagimet Biosciences Appoints Andreas Grauer as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2629756080","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629756080?lang=en_us&edition=fundamental","pubTime":"2026-04-21 18:38","pubTimestamp":1776767887,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences, Inc. Class A ( ($SGMT) ) just unveiled an announcement. On April 20, 2026, Sagimet Biosciences, Inc. Class A appointed Andreas...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sagimet-biosciences-appoints-andreas-grauer-as-chief-medical-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sagimet-biosciences-appoints-andreas-grauer-as-chief-medical-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4568","BK4548","BK4585","BK4551","BK4139","SGMT","BNTX","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628174259","title":"Sagimet names Andreas Grauer chief medical officer as Eduardo Martins retires","url":"https://stock-news.laohu8.com/highlight/detail?id=2628174259","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628174259?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:01","pubTimestamp":1776682896,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences appointed Andreas Grauer as chief medical officer, effective April 20, 2026.Grauer most recently served as chief medical officer at Omeros, leading clinical, safety, and medical functions for complement-targeted therapies.Martins will continue to support Sagimet as an external scientific advisor.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sagimet Biosciences Inc. published the original content used to generate this news brief on April 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL3YnvGb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","SGMT","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628373742","title":"Press Release: Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2628373742","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628373742?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:00","pubTimestamp":1776682800,"startTime":"0","endTime":"0","summary":"SAN MATEO, Calif., April 20, 2026  -- Sagimet Biosciences Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced the appointment of Andreas Grauer, MD, as Chief Medical Officer, effective April 20, 2026. Sagimet's prior Chief Medical Officer, Eduardo Bruno Martins, MD, DPhil, who will continue to support the Company as an external scientific advisor, has retired effective April 20, 2026.\"We are delighted to welcome Dr. Andreas Grauer to our executive leadership team as Chief Medical Officer. Dr. Grauer has an extensive track record in leading clinical development and medical affairs in global pharmaceutical organizations as well as an impressive academic career. His expertise and insights will be key as we advance our FASN inhibitors in clinical development,\" said David Happel, Chief Executive Officer of Sagimet. \"We also want to thank Dr. Eduardo Martins for his many significant contribut","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4568","SGMT","BNTX","BK4585","BK4551","OMER","BK4535","BK4548","BK4139","MD","BK4007","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625676834","title":"Sagimet grants 9,600 inducement stock options to new hire under Nasdaq rule exception","url":"https://stock-news.laohu8.com/highlight/detail?id=2625676834","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625676834?lang=en_us&edition=fundamental","pubTime":"2026-04-06 19:00","pubTimestamp":1775473220,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences granted stock options covering 9,600 shares to a newly hired employee on April 3, 2026.Award vests over four years, with 25% vesting after one year.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nNDLc0TRj9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014013.SGD","SGMT","IE00B3QW5Z07.USD","BK4585","BK4139","IE00BGHQF748.EUR","IE00BN0W2W23.USD","BK4588","SG9999014039.USD","LU2210150020.SGD","NDAQ","BK4112","LU2095319765.USD","SG9999014005.SGD","IE00BKPKM429.USD","SG9999014021.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625763476","title":"Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625763476","media":"GlobeNewswire","labels":["shareholding","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625763476?lang=en_us&edition=fundamental","pubTime":"2026-04-06 19:00","pubTimestamp":1775473200,"startTime":"0","endTime":"0","summary":"SAN MATEO, Calif., April  06, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabol","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/06/3268332/0/en/Sagimet-Biosciences-Announces-Poster-and-Oral-Presentations-at-the-Fueling-MASH-Metabolic-Drivers-and-Inflammatory-Crosstalk-Keystone-Symposium-and-Inducement-Grant-Under-Nasdaq-Li.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":119,"code":"91000000","status":"200"}]}}